SHLS: Sexual Health Literacy Scale

Sponsor
Nurdan Demirci (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05821907
Collaborator
(none)
400
5.3

Study Details

Study Description

Brief Summary

According to the World Health Organization, sexual health is a state of well-being related to sexuality as a whole, not just the absence of disease or dysfunction or disability. sexual health; It requires a positive and respectful attitude, free from sexual coercion and discrimination, free of violence, enjoyable and safe experiences. It obliges the respect, protection and fulfillment of the sexual rights of every individual. sexual health; includes a safe and respectful framework free from violence and discrimination; it covers not only the reproductive period, but every age period; different sexual identities and forms of sexual expression, as well as livable and critical gender values, roles, expectations and power dynamics. Insufficient information, difficult access to health services and lack of a guiding structure; It negatively affects young individuals' ability to take responsible decisions with good knowledge about sexuality during their sexual development. Information is obtained from channels where erroneous and incorrect information transfer is intense, and the ways of accessing this information play an important role in the spread of sexual myths in society. Based on all these reasons; This study aimed to develop the Sexual Health Literacy Scale.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: data collection group

Study Design

Study Type:
Observational
Anticipated Enrollment :
400 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Development of the Sexual Health Literacy Scale
Anticipated Study Start Date :
Apr 22, 2023
Anticipated Primary Completion Date :
Jun 30, 2023
Anticipated Study Completion Date :
Sep 30, 2023

Outcome Measures

Primary Outcome Measures

  1. scale development [3 month]

    The data will be collected with the online data collection tool created by the researchers through the software called google forms. During data collection, the e-mail address of the researchers will be indicated on the form so that the questions of the participants can be answered by the researchers. You will be informed that filling out the data collection form will take an average of 10 minutes for each participant. In addition, in order to evaluate the test-retest reliability of the scale, data collection tools will be sent to at least 30 randomly selected individuals from the sample two weeks after the first data collection.

  2. test-retest reliability of the scale [Retest( later 2 weeks)]

    In order to evaluate the test-retest reliability of the scale, data collection tools will be sent to at least 30 randomly selected individuals from the sample two weeks after the first data collection. Therefore, after the pre-application, the scale will be applied to 400 people within the scope of the calculated sample, and then, two weeks later, at least 50 people will be re-applied from the individuals to whom the same scale was applied.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Individuals over the age of 18 who are willing to participate in the study, without psychiatric illness,

  • No physical or mental disability

  • Able to speak and understand Turkish.

Exclusion Criteria:
  • Not willing to participate in the study, with psychiatric illness,

  • Physically and mentally handicapped

  • 18 years and under,

  • Does not speak Turkish

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Nurdan Demirci

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nurdan Demirci, Prof, Marmara University
ClinicalTrials.gov Identifier:
NCT05821907
Other Study ID Numbers:
  • 2023.shls.olmezyalazi
First Posted:
Apr 20, 2023
Last Update Posted:
Apr 20, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Apr 20, 2023